BAKER (Schzio pedophile) ID: eb5471 Aug. 6, 2022, 10:05 p.m. No.17103551   🗄️.is 🔗kun

>>17102643

>>17103332

>And that BO hasn't changed, and that admin hasn't decided "fuck the rules I am admin". Don't forget those possibilities.

Jim refuses to show the board log to prove the board wasn't claimed after 18 months. Wonder why?

Anonymous ID: eb5471 Aug. 6, 2022, 10:06 p.m. No.17103646   🗄️.is 🔗kun

>>17102351

>sugar

ADHD

 

What's missing?

ADHD

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702182/

 

Objective: The purpose of this study was to investigate the clinical effect and safety of a broad spectrum, 36 ingredient micronutrient (vitamins and minerals) in treating children with attention-deficit/hyperactivity disorder (ADHD).

 

Results: Modified Brinley plots revealed a reduction in ADHD symptoms, improved mood, and improved overall functioning during intervention phases, and deterioration in ADHD symptoms, mood, and overall functioning during the withdrawal phases. Reliable change analyses, Cohen's d and percent superiority effect sizes, 95% confidence intervals and t tests confirmed clinically and statistically significant change between the intervention and withdrawal phases, with large effect sizes observed pre- to post-exposure of micronutrients (d = 1.2–2.2) on ADHD symptoms during intervention phases. Seventy-one percent of participants showed at least a 30% decrease in ADHD symptoms by the end of the second treatment phase, and 79% were identified as “much improved” or “very much improved” at the end of the second phase (5 months) based on the clinician-rated CGI when considering functioning generally. The SDQ showed that these benefits occurred across other areas of functioning including emotional symptoms, conduct problems, and prosocial behaviours. The children's self-reports confirmed the improvements. Excellent adherence to treatment occurred throughout, side effects were mild and transitory, and no safety issues were identified through blood analyses.

 

Conclusions: This study demonstrates the clinical benefit, feasibility, and safety of broad-spectrum micronutrients in the treatment of childhood ADHD. Replications utilizing double-blind placebo-controlled studies are warranted. Trial is registered with the Australia and New Zealand Clinical Trial Registry: ACTRN12612000645853

 

Table 1.

 

EMPowerplus Capsule Ingredient List

1 capsule 4 capsules 8 capsules 15 capsules

Vitamin A 384.0 IM 1536.0 IM 3072.0 IM 5760 IM

Vitamin C 40.0 mg 160.0 mg 320.0 mg 600 mg

Vitamin D 96.0 IM 384.0 IM 768.0 IM 1440 IM

Vitamin E 24.0 IM 96.0 IM 192.0 IM 360 IM

Vitamin B1 1.2 mg 4.8 mg 9.6 mg 18 mg

Vitamin B2 0.9 mg 3.6 mg 7.2 mg 13.5 mg

Vitamin B3 6.0 mg 24.0 mg 48.0 mg 90 mg

Vitamin B5 1.4 mg 5.8 mg 11.5 mg 21.6 mg

Vitamin B6 2.4 mg 9.6 mg 19.2 mg ?36 mg

Vitamin B9 96.0 µg 384.0 µg 768.0 µg 1440 µg

Vitamin B12 60.0 µg 240.0 µg 480.0 µg 900 µg

Vitamin H 72.0 µg 288.0 µg 576.0 µg 1080 µg

Calcium 88.0 mg 352.0 mg 704.0 mg 1320 mg

Iron 0.9 mg 3.7 mg 7.3 mg 13.74 mg

Phosphorus 56.0 mg 224.0 mg 448.0 mg 840 mg

Iodine 13.6 µg 54.4 µg 108.8 µg 204 µg

Magnesium 40.0 mg 160.0 mg 320.0 mg 600 mg

Zinc 3.2 mg 12.8 mg 25.6 mg 48 mg

Selenium 13.6 µg 54.4 µg 108.8 µg 204 µg

Copper 0.5 mg 1.9 mg 3.8 mg 7.2 mg

Managnese 0.6 mg 2.6 mg 5.1 mg 9.6 mg

Chromium 41.6 µg 166.4 µg 332.8 µg 624 µg

Molybdenum 9.6 µg 38.4 µg 76.8 µg 144 µg

Potassium 16.0 mg 64.0 mg 128.0 mg 240 mg

 

Plus a proprietary blend of: dl-phenylalanine, glutamine, citrus bioflavanoids, grape seed, choline bitartrate, inositol, ginkgo biloba, methionine, germanium sesquioxide, boron, nickel, and vanadium.

 

Coincidences